Cochrane Abstracts
Galantamine for dementia in people with Down syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Galantamine for Dementia in People With Down Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437807/all/Galantamine_for_dementia_in_people_with_Down_syndrome.
Galantamine for dementia in people with Down syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437807/all/Galantamine_for_dementia_in_people_with_Down_syndrome. Accessed December 3, 2024.
Galantamine for dementia in people with Down syndrome. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437807/all/Galantamine_for_dementia_in_people_with_Down_syndrome
Galantamine for Dementia in People With Down Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437807/all/Galantamine_for_dementia_in_people_with_Down_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Galantamine for dementia in people with Down syndrome
ID - 437807
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437807/all/Galantamine_for_dementia_in_people_with_Down_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
